These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32816299)

  • 1. [From Adam to ecstacy; legal use of MDMA in the 1970s and 1980s].
    Blok G
    Tijdschr Psychiatr; 2020; 62(8):702-706. PubMed ID: 32816299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The History of MDMA as an Underground Drug in the United States, 1960-1979.
    Passie T; Benzenhöfer U
    J Psychoactive Drugs; 2016; 48(2):67-75. PubMed ID: 26940772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA: interactions with other psychoactive drugs.
    Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA interactions with pharmaceuticals and drugs of abuse.
    Papaseit E; Pérez-Mañá C; Torrens M; Farré A; Poyatos L; Hladun O; Sanvisens A; Muga R; Farré M
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):357-369. PubMed ID: 32228243
    [No Abstract]   [Full Text] [Related]  

  • 5. [The development of a rational national MDMA policy and its relevance for psychiatry].
    van Amsterdam JGC; Nabben T; Peters GJ; van Bakkum F; Noijen J; van den Brink W
    Tijdschr Psychiatr; 2021; 63(9):665-672. PubMed ID: 34647305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a case for MDMA-assisted psychotherapy in the UK?
    Sessa B
    J Psychopharmacol; 2007 Mar; 21(2):220-4. PubMed ID: 17329304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploration of the history and controversies surrounding MDMA and MDA.
    Pentney AR
    J Psychoactive Drugs; 2001; 33(3):213-21. PubMed ID: 11718314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An MDMA cluster and the utility of illicit drug blood sampling.
    Kozman A; Soderstrom J; Oosthuizen F; Fatovich D
    Clin Toxicol (Phila); 2022 Oct; 60(10):1187-1188. PubMed ID: 36069775
    [No Abstract]   [Full Text] [Related]  

  • 9. Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia.
    Peacock A; Gibbs D; Price O; Barratt MJ; Ezard N; Sutherland R; Hill PL; Grigg J; Lenton S; Page R; Salom C; Hughes C; Bruno R
    Int J Drug Policy; 2021 Nov; 97():103334. PubMed ID: 34246017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy).
    Więckiewicz G; Danel D; Piegza M; Gorczyca PW; Pudlo R
    Psychiatr Pol; 2022 Oct; 56(5):1109-1130. PubMed ID: 37074860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic drugs-a new era in
psychiatry?
.
    Nutt D
    Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of MDMA (ecstasy) use and neurotoxicity.
    Franken IH
    Eur Psychiatry; 2001 Dec; 16(8):508-9. PubMed ID: 11777745
    [No Abstract]   [Full Text] [Related]  

  • 13. MDMA (Ecstacy): useful information for health professionals involved in drug education programs.
    Elk C
    J Drug Educ; 1996; 26(4):349-56. PubMed ID: 9071057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecstasy: as harmful as heroin?
    Scott R
    J Law Med; 2009 Dec; 17(3):327-48. PubMed ID: 20169795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.
    Edland-Gryt M; Sandberg S; Pedersen W
    Int J Drug Policy; 2017 Dec; 50():1-8. PubMed ID: 28869878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy.
    Mitchell J; Coker A; Yazar-Klosinski B
    Nat Med; 2021 Oct; 27(10):1691-1692. PubMed ID: 34635856
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study.
    Bobes J; Sáiz PA; González MP; Bascarán MT; Bousoño M; Ricaurte GA; McCann UD
    Eur Addict Res; 2002 Jun; 8(3):147-54. PubMed ID: 12065965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plusridisciplinary approaches to understand the neutoxic effects of Ecstasy].
    Roques BP; Noble F
    Ann Pharm Fr; 2003 May; 61(3):157-63. PubMed ID: 12714928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.